Global Maternal Health Market - 2023-2030

Global Maternal Health Market - 2023-2030


The Global Maternal Health Market reached US$ 14.1 billion in 2022 and is expected to reach US$ 28.3 billion by 2030 growing with a CAGR of 8.5% during the forecast period 2023-2030.

The maternal health market is driven by factors such as increasing awareness and education, rising maternal age, government initiatives, growing healthcare infrastructure and awareness of maternal mental health.

Regular medical check-ups, screenings, and testing are part of proper prenatal care during pregnancy. The health of the mother and the growing fetus is ensured through early detection and treatment of any potential issues. The health of the mother and the unborn child depends on eating a good and balanced diet. The growth and development of the fetus are supported by an adequate intake of necessary nutrients, which also protects the mother's health.

Dynamics

The Increasing Collaboration Among Key Players is Driving the Global Maternal Health Market Growth

In May 2023, in order to commercialize distinctive and ground-breaking products in the areas of Maternal Health & Urology, CORONA Remedies Private Limited (CORONA) entered into an agreement with Ferring Pharmaceuticals Pvt. Ltd. (Ferring), a subsidiary of global biopharmaceuticals company Ferring Pharmaceuticals with headquarters in Switzerland.

The partnership between CORONA and Ferring will provide patients all over India with cutting-edge products, some of which will be from international brands, to meet the unmet treatment requirements in urology and maternal health. They are thrilled to collaborate with Ferring, a research-driven, specialty biopharmaceutical group, to provide patients in India with top-notch medications.

The Increasing Funding for Maternal Health Boost The Global Maternal Health Market Growth

In January 2023, The Christian Medical College (CMC) in Vellore, Tamil Nadu, now has an advanced simulation lab center due to the U.S. Agency for International Development (USAID). The lab will be used to train medical professionals in maternal and neonatal care, including CPR, basic and advanced nursing techniques, and the newest technologies to address maternal health and newborn emergencies.

The American Schools and Hospitals Abroad (ASHA) program of USAID provides a $1 million (USD) grant to fund the Advanced Simulation Lab Center. ASHA works to create friendly and mutually beneficial relationships between Americans and Indians. Since patient safety, protocols, and debriefing methods are crucial for student evaluation and feedback, the institution adopts American best practices in these areas. Modern supplies and equipment for the hospital's neonatal critical care unit and labor and delivery rooms were also made possible by USAID through this effort.

Challenges with Maternal Health are Hampering the Global Maternal Health Market Growth

There are discrepancies in access to high-quality healthcare services in many areas, especially for underserved people, which has a negative impact on maternal health outcomes. Poor prenatal care can stem from a lack of knowledge and understanding about proper maternal health care, which could cause issues throughout pregnancy and childbirth. For many women, particularly in low-income or uninsured populations, the expense of high-quality maternal health services, including prenatal care, delivery, and postnatal care, can be prohibitive.

Segment Analysis

The global maternal health market is segmented based on treatment, indication, distribution channel, and region.

The Hormones Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period

The hormones segment accounted for the highest market stake accounting for approximately 45.4% of the maternal health market in 2022. Hormones and maternal health are tightly related during pregnancy and the postpartum period. The different physiological and mental changes that take place in a woman's body during pregnancy and after childbirth are significantly regulated by hormones.

For the mother's and the fetus's health to be maintained during pregnancy, specific hormones must be produced in greater quantities. The most notable hormones involved in pregnancy are progesterone, estrogen, human chorionic gonadotropin hormone (hCG), and human placental lactogen (hPL). A hormone called progesterone is essential for preserving the uterine lining and avoiding contractions. Progesterone supplements may occasionally be advised for women who have a history of recurrent miscarriages or who have a short cervix.

Geographical Penetration

North America Holds a Dominant Position in the Global Maternal Health Market

North America is estimated to hold around 1/3rd of the total market share throughout the forecast period. In October 2022, The Special Supplemental Nutrition Program for Women, Infants, and Children, or WIC, has undergone significant modernization and innovation, and the U.S. Department of Agriculture recognizes its accomplishment and promise. The American Rescue Plan Act of 2021 has provided funding for three significant awards totaling about $53 million, as part of the efforts.

Together, these investments will increase the number of eligible women and young children that WIC reaches, improve the level of care that they get throughout their involvement with the program, and assist to close long-standing gaps in maternal and child health.

Competitive Landscape
The major global players in the market include Johnson & Johnson, Jiovio Healthcare, Pfizer Inc., GlaxoSmithKline Inc., Merck & Co., Inc., RAND Corporation, SYNAPSE Product Development, Siemens, Reckitt Benckiser Group Plc, Sanofi among others.

COVID-19 Impact Analysis

Russia-Ukraine Conflict Analysis

The Russia-Ukraine war may affect the maternal health market due to a lack of facilities being impacted during times of geopolitical instability and economic uncertainty. It may be challenging for expectant mothers to get adequate prenatal and postnatal care if healthcare facilities are damaged or destroyed as a result of the conflict. Conflict zones' hospitals and clinics may be overburdened or unable to deliver proper care.

Artificial Intelligence Analysis:

Artificial intelligence (AI) is increasingly being used in the maternal health market to improve various aspects of data analysis. A pregnant woman's medical history, health information, and lifestyle choices can be analyzed by AI algorithms to identify potential risk factors and forecast difficulties during pregnancy. This enables medical practitioners to develop individualized care regimens and intervene early.

Pregnant women can remotely monitor their health due to wearable technology and mobile apps that are powered by AI. These gadgets can monitor fetal movements, contraction patterns, and other pertinent information, alerting medical professionals if any unsettling trends are found.

By Treatment
• Hormones
• Nutritives
• Analgesics
• Anti-Infectives
• Others

By Indication
• Miscarriage
• Premature Labor and Birth
• Others

By Distribution channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• In March 2023, MedArrive, the top mobile-integrated care management solution, announced a partnership with Ouma Health, a provider of whole maternity telehealth services, in order to provide complete maternal-fetal care to at-risk women on Medicaid. By including a crucial service into MedArrive's expanding ecosystem of specialized care providers that managed Medicaid health plans can utilize for members in their homes, the collaboration intends to improve the health of expectant mothers and their newborns, particularly those at high risk.

Why Purchase the Report?
• To visualize the global maternal health market segmentation based on the treatment, indication, distribution channel, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of maternal health market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of critical products of all the major players.

The global maternal health market report would provide approximately 61 tables, 57 figures, and 195 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Treatment
3.2. Snippet by Indication
3.3. Snippet by Distribution Channel
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising collaboration among key players
4.1.2. Restraints
4.1.2.1. Challenges associated with maternal health
4.1.3. Opportunity
4.1.3.1. Technological advancements
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Artificial Intelligence Analysis
9. By Treatment
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
9.1.2. Market Attractiveness Index, By Treatment
9.2. Hormones*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Nutritives
9.4. Analgesics
9.5. Anti-Infectives
9.6. Others
10. By Indication
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.1.2. Market Attractiveness Index, By Indication
10.2. Miscarriage*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Premature Labor and Birth
10.4. Others
11. By Distribution Channel
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.1.2. Market Attractiveness Index, By Distribution Channel
11.2. Hospital Pharmacies*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Retail Pharmacies
11.4. Online Pharmacies
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.6.1. U.S.
12.2.6.2. Canada
12.2.6.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.6.1. Germany
12.3.6.2. U.K.
12.3.6.3. France
12.3.6.4. Italy
12.3.6.5. Spain
12.3.6.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.6.1. Brazil
12.4.6.2. Argentina
12.4.6.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.6.1. China
12.5.6.2. India
12.5.6.3. Japan
12.5.6.4. Australia
12.5.6.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Product Benchmarking
13.3. Company Share Analysis
13.4. Key Developments and Strategies
14. Company Profiles
14.1. Johnson & Johnson*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Jiovio Healthcare
14.3. Pfizer Inc
14.4. GlaxoSmithKline Inc.
14.5. Merck & Co., Inc.
14.6. RAND Corporation
14.7. SYNAPSE Product Development
14.8. Siemens
14.9. Reckitt Benckiser Group Plc
14.10. Sanofi
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings